Tuleu, C;
Kendall, R;
Lenoir, J;
Gerrard, S;
Scheuerle, RL;
Slater, NKH;
(2017)
Using the Slug Mucosal Irritation assay to investigate the tolerability of tablet excipients on human skin in the context of the use of a nipple shield delivery system.
Pharmaceutical Research
, 34
(4)
pp. 687-695.
10.1007/s11095-016-1997-y.
Preview |
Text
Tuleu_Using the Slug Mucosal Irritation assay_combined.pdf Download (859kB) | Preview |
Abstract
PURPOSE: Neonates are particularly challenging to treat. A novel patented drug delivery device containing a rapidly disintegrating tablet held within a modified nipple shield (NSDS) was designed to deliver medication to infants during breastfeeding. However concerns exist around dermatological nipple tolerability with no pharmaceutical safety assessment guidance to study local tissue tolerance of the nipple and the areola. This is the first Slug Mucosal Irritation (SMI) study to evaluate irritancy potential of GRAS excipients commonly used to manufacture rapidly disintegrating immediate release solid oral dosage form. METHODS: Zinc sulphate selected as the antidiarrheal model drug that reduces infant mortality, was blended with functional excipients at traditional levels [microcrystalline cellulose, sodium starch glycolate, croscarmellose sodium, magnesium stearate]. Slugs were exposed to blends slurried in human breast milk to assess their stinging, itching or burning potential, using objective values such as mucus production to categorize irritation potency. Results: Presently an in vivo assay, previously validated for prediction of ocular and nasal irritation, was used as an alternative to vertebrate models to anticipate the potential maternal dermatological tolerability issues to NSDS tablet components. The excipients did not elicit irritancy. However, mild irritancy was observed when zinc sulphate was present in blends. CONCLUSION: These promising good tolerability results support the continued investigation of these excipients within NSDS rapidly disintegrating tablet formulations. Topical local tolerance effects being almost entirely limited to irritation, the slug assay potentially adds to the existing preformulation toolbox, and may sit in between the in vitro and existing in vivo assays.
| Type: | Article |
|---|---|
| Title: | Using the Slug Mucosal Irritation assay to investigate the tolerability of tablet excipients on human skin in the context of the use of a nipple shield delivery system |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1007/s11095-016-1997-y |
| Publisher version: | http://dx.doi.org/10.1007/s11095-016-1997-y |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Nipple Shield Delivery System, Slug Mucosal Irritation Assay, Skin Tolerability, Tablet Excipients, Pediatric |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1519657 |
Loading...
Loading...Loading...| 1. |  United States | 16 |
| 2. |  China | 6 |
| 3. |  United Kingdom | 6 |
| 4. |  Germany | 5 |
| 5. |  Russian Federation | 4 |
| 6. |  Japan | 3 |
| 7. |  Italy | 2 |
| 8. |  India | 2 |
| 9. |  Korea, Republic of | 1 |
| 10. |  Romania | 1 |
Archive Staff Only
 |
View Item |
